+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Direct-to-Consumer Laboratory Testing Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

  • ID: 5522392
  • Report
  • November 2021
  • Region: Europe
  • 197 Pages
  • Transparency Market Research
the publisher’s report on the direct-to-consumer laboratory testing market in Europe studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the revenue of the direct-to-consumer laboratory testing market in Europe for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the direct-to-consumer laboratory testing market in Europe for the forecast period.



The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the direct-to-consumer laboratory testing market in Europe.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomena in the direct-to-consumer laboratory testing market in Europe.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the direct-to-consumer laboratory testing market in Europe. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the direct-to-consumer laboratory testing market in Europe. The next section of the direct-to-consumer laboratory testing market report highlights the USPs such as key industrial events (licensing partnership/merger & acquisition), disease epidemiology by region/country, COVID-19 pandemic impact on industry (value chain and short/mid/long-term impact), and key success factors of top players operating in the direct-to-consumer laboratory testing market in Europe.

The report also delves into the competition landscape of the direct-to-consumer laboratory testing market in Europe. Key players operating in the direct-to-consumer laboratory testing market in Europe have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, strategic overview, and SWOT are some of the attributes of players in the direct-to-consumer laboratory testing market in Europe profiled in this report.

Key Questions Answered in Europe Direct-to-Consumer Laboratory Testing Market Report


  • What are the major drivers, restraints, and opportunities in the market?
  • What are the revenue share projections of key segments of the direct-to-consumer laboratory testing market in Europe during the forecast period?
  • Which segment is likely to lead the direct-to-consumer laboratory testing market in Europe in terms of revenue by 2031?
  • How technological developments are widening the scope for the direct-to-consumer laboratory testing market in Europe?
  • What is the market position of different companies operating in the direct-to-consumer laboratory testing market in in Europe?

Europe Direct-to-Consumer Laboratory Testing Market - Research Objectives and Research Approach


The comprehensive report on the direct-to-consumer laboratory testing market in Europe begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind the study and healthcare compliances laid down by accredited agencies in the purview of research in the direct-to-consumer laboratory testing market in Europe. It is followed by market introduction, market dynamics, and an overview of the direct-to-consumer laboratory testing market in Europe, which includes the publisher analysis of market drivers, restraints, and opportunities affecting the growth of the direct-to-consumer laboratory testing market in Europe. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the direct-to-consumer laboratory testing market in Europe.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the direct-to-consumer laboratory testing market in in Europe in terms of test type, sample type, provider, and country. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the direct-to-consumer laboratory testing market.
Frequently Asked Questions about the European Direct-to-Consumer Laboratory Testing Market

What is the estimated value of the European Direct-to-Consumer Laboratory Testing Market?

The European Direct-to-Consumer Laboratory Testing Market was estimated to be valued at $774.4 Million in 2021.

What is the growth rate of the European Direct-to-Consumer Laboratory Testing Market?

The growth rate of the European Direct-to-Consumer Laboratory Testing Market is 26.0%, with an estimated value of $7835.1 Million by 2031.

What is the forecasted size of the European Direct-to-Consumer Laboratory Testing Market?

The European Direct-to-Consumer Laboratory Testing Market is estimated to be worth $7835.1 Million by 2031.

Who are the key companies in the European Direct-to-Consumer Laboratory Testing Market?

Key companies in the European Direct-to-Consumer Laboratory Testing Market include 23andMe, Inc., Ancestry, CircleDNA, Eurofins Scientific, Family Tree DNA (Gene by Gene), Laboratory Corporation of America Holdings, Living DNA Ltd., Medichecks.com Ltd. and MyMedLab, Inc..

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology3. Executive Summary: Europe Direct-to-Consumer Laboratory Testing Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industrial Events (licensing partnerships/mergers & acquisitions)
5.2. Disease Prevalence & Incidence Rate
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Sample Type, 2017-2031
6.3.1. Blood
6.3.2. Urine
6.3.3. Saliva
6.3.4. Others
6.4. Market Attractiveness Analysis, by Sample Type
7. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Test Type, 2017-2031
7.3.1. Genetic Testing
7.3.1.1. Nutrigenetics Test
7.3.1.1.1. Weight Control
7.3.1.1.2. Lactose Intolerance
7.3.1.1.3. Others
7.3.1.2. Celiac Disease Test
7.3.1.3. Sports & Physical Activity Testing
7.3.1.4. Men's Health Tests
7.3.1.5. Women's Health Tests
7.3.1.6. Pregnancy & Prenatal Screening Test
7.3.1.7. General Health Testing
7.3.1.8. Others
7.3.2. Disease Risk Assessment Testing
7.3.2.1. Sexual Health Tests
7.3.2.1.1. HIV
7.3.2.1.2. Chlamydia
7.3.2.1.3. Others
7.3.2.2. Cancer Predisposition Tests
7.3.2.3. Others
7.3.3. CBC
7.3.4. Chronic Disease Testing
7.3.4.1. Diabetes Testing
7.3.4.2. Hypertension
7.3.4.3. Others
7.3.5. COVID-19 Testing
7.3.6. TSH Testing
7.3.7. Others
7.4. Market Attractiveness Analysis, by Test Type
8. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Provider
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Provider, 2017-2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Speciality Labs
8.3.4. Diagnostic Centres
8.4. Market Attractiveness Analysis, by Provider
9. Germany Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Sample Type, 2017-2031
9.2.1. Blood
9.2.2. Urine
9.2.3. Saliva
9.2.4. Others
9.3. Market Value Forecast, by Test Type, 2017-2031
9.3.1. Genetic Testing
9.3.1.1. Nutrigenetics Test
9.3.1.1.1. Weight Control
9.3.1.1.2. Lactose Intolerance
9.3.1.1.3. Others
9.3.1.2. Celiac Disease Test
9.3.1.3. Sports & Physical Activity Testing
9.3.1.4. Men's Health Tests
9.3.1.5. Women's Health Tests
9.3.1.6. Pregnancy & Prenatal Screening Test
9.3.1.7. General Health Testing
9.3.1.8. Others
9.3.2. Disease Risk Assessment Testing
9.3.2.1. Sexual Health Tests
9.3.2.1.1. HIV
9.3.2.1.2. Chlamydia
9.3.2.1.3. Others
9.3.2.2. Cancer Predisposition Tests
9.3.2.3. Others
9.3.3. CBC
9.3.4. Chronic Disease Testing
9.3.4.1. Diabetes Testing
9.3.4.2. Hypertension
9.3.4.3. Others
9.3.5. COVID-19 Testing
9.3.6. TSH Testing
9.3.7. Others
9.4. Market Value Forecast, by Provider, 2017-2031
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Speciality Labs
9.4.4. Diagnostic Centres
10. U.K. Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Sample Type, 2017-2031
10.2.1. Blood
10.2.2. Urine
10.2.3. Saliva
10.2.4. Others
10.3. Market Value Forecast, by Test Type, 2017-2031
10.3.1. Genetic Testing
10.3.1.1. Nutrigenetics Test
10.3.1.1.1. Weight Control
10.3.1.1.2. Lactose Intolerance
10.3.1.1.3. Others
10.3.1.2. Celiac Disease Test
10.3.1.3. Sports & Physical Activity Testing
10.3.1.4. Men's Health Tests
10.3.1.5. Women's Health Tests
10.3.1.6. Pregnancy & Prenatal Screening Test
10.3.1.7. General Health Testing
10.3.1.8. Others
10.3.2. Disease Risk Assessment Testing
10.3.2.1. Sexual Health Tests
10.3.2.1.1. HIV
10.3.2.1.2. Chlamydia
10.3.2.1.3. Others
10.3.2.2. Cancer Predisposition Tests
10.3.2.3. Others
10.3.2.4. CBC
10.3.2.5. Chronic Disease Testing
10.3.2.5.1. Diabetes Testing
10.3.2.5.2. Hypertension
10.3.2.5.3. Others
10.3.2.6. COVID-110 Testing
10.3.2.7. TSH Testing
10.3.2.8. Others
10.4. Market Value Forecast, by Provider, 2017-2031
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Speciality Labs
10.4.4. Diagnostic Centres
11. France Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Sample Type, 2017-2031
11.2.1. Blood
11.2.2. Urine
11.2.3. Saliva
11.2.4. Others
11.3. Market Value Forecast, by Test Type, 2017-2031
11.3.1. Genetic Testing
11.3.1.1. Nutrigenetics Test
11.3.1.1.1. Weight Control
11.3.1.1.2. Lactose Intolerance
11.3.1.1.3. Others
11.3.1.2. Celiac Disease Test
11.3.1.3. Sports & Physical Activity Testing
11.3.1.4. Men's Health Tests
11.3.1.5. Women's Health Tests
11.3.1.6. Pregnancy & Prenatal Screening Test
11.3.1.7. General Health Testing
11.3.1.8. Others
11.3.2. Disease Risk Assessment Testing
11.3.2.1. Sexual Health Tests
11.3.2.1.1. HIV
11.3.2.1.2. Chlamydia
11.3.2.1.3. Others
11.3.2.2. Cancer Predisposition Tests
11.3.2.3. Others
11.3.3. CBC
11.3.4. Chronic Disease Testing
11.3.4.1. Diabetes Testing
11.3.4.2. Hypertension
11.3.4.3. Others
11.3.5. COVID-19 Testing
11.3.6. TSH Testing
11.3.7. Others
11.4. Market Value Forecast, by Provider, 2017-2031
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Speciality Labs
11.4.4. Diagnostic Centres
12. Italy Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Sample Type, 2017-2031
12.2.1. Blood
12.2.2. Urine
12.2.3. Saliva
12.2.4. Others
12.3. Market Value Forecast, by Test Type, 2017-2031
12.3.1. Genetic Testing
12.3.1.1. Nutrigenetics Test
12.3.1.1.1. Weight Control
12.3.1.1.2. Lactose Intolerance
12.3.1.1.3. Others
12.3.1.2. Celiac Disease Test
12.3.1.3. Sports & Physical Activity Testing
12.3.1.4. Men's Health Tests
12.3.1.5. Women's Health Tests
12.3.1.6. Pregnancy & Prenatal Screening Test
12.3.1.7. General Health Testing
12.3.1.8. Others
12.3.2. Disease Risk Assessment Testing
12.3.2.1. Sexual Health Tests
12.3.2.1.1. HIV
12.3.2.1.2. Chlamydia
12.3.2.1.3. Others
12.3.2.2. Cancer Predisposition Tests
12.3.2.3. Others
12.3.3. CBC
12.3.4. Chronic Disease Testing
12.3.4.1. Diabetes Testing
12.3.4.2. Hypertension
12.3.4.3. Others
12.3.5. COVID-19 Testing
12.3.6. TSH Testing
12.3.7. Others
12.4. Market Value Forecast, by Provider, 2017-2031
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Speciality Labs
12.4.4. Diagnostic Centres
13. Spain Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Sample Type, 2017-2031
13.2.1. Blood
13.2.2. Urine
13.2.3. Saliva
13.2.4. Others
13.3. Market Value Forecast, by Test Type, 2017-2031
13.3.1. Genetic Testing
13.3.1.1. Nutrigenetics Test
13.3.1.1.1. Weight Control
13.3.1.1.2. Lactose Intolerance
13.3.1.1.3. Others
13.3.1.2. Celiac Disease Test
13.3.1.3. Sports & Physical Activity Testing
13.3.1.4. Men's Health Tests
13.3.1.5. Women's Health Tests
13.3.1.6. Pregnancy & Prenatal Screening Test
13.3.1.7. General Health Testing
13.3.1.8. Others
13.3.2. Disease Risk Assessment Testing
13.3.2.1. Sexual Health Tests
13.3.2.1.1. HIV
13.3.2.1.2. Chlamydia
13.3.2.1.3. Others
13.3.2.2. Cancer Predisposition Tests
13.3.2.3. Others
13.3.3. CBC
13.3.4. Chronic Disease Testing
13.3.4.1. Diabetes Testing
13.3.4.2. Hypertension
13.3.4.3. Others
13.3.5. COVID-19 Testing
13.3.6. TSH Testing
13.3.7. Others
13.4. Market Value Forecast, by Provider, 2017-2031
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Speciality Labs
13.4.4. Diagnostic Centres
14. Rest of Europe Countries Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Sample Type, 2017-2031
14.2.1. Blood
14.2.2. Urine
14.2.3. Saliva
14.2.4. Others
14.3. Market Value Forecast, by Test Type, 2017-2031
14.3.1. Genetic Testing
14.3.1.1. Nutrigenetics Test
14.3.1.1.1. Weight Control
14.3.1.1.2. Lactose Intolerance
14.3.1.1.3. Others
14.3.1.2. Celiac Disease Test
14.3.1.3. Sports & Physical Activity Testing
14.3.1.4. Men's Health Tests
14.3.1.5. Women's Health Tests
14.3.1.6. Pregnancy & Prenatal Screening Test
14.3.1.7. General Health Testing
14.3.1.8. Others
14.3.2. Disease Risk Assessment Testing
14.3.2.1. Sexual Health Tests
14.3.2.1.1. HIV
14.3.2.1.2. Chlamydia
14.3.2.1.3. Others
14.3.2.2. Cancer Predisposition Tests
14.3.2.3. Others
14.3.3. CBC
14.3.4. Chronic Disease Testing
14.3.4.1. Diabetes Testing
14.3.4.2. Hypertension
14.3.4.3. Others
14.3.5. COVID-19 Testing
14.3.6. TSH Testing
14.3.7. Others
14.4. Market Value Forecast, by Provider, 2017-2031
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Speciality Labs
14.4.4. Diagnostic Centres
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. 23andMe, Inc.
15.2.1.1. Company Description
15.2.1.2. Business Overview
15.2.1.3. Strategic Overview
15.2.1.4. SWOT Analysis
15.2.2. Ancestry
15.2.2.1. Company Description
15.2.2.2. Business Overview
15.2.2.3. SWOT Analysis
15.2.3. CircleDNA
15.2.3.1. Company Description
15.2.3.2. Business Overview
15.2.3.3. SWOT Analysis
15.2.4. Eurofins Scientific
15.2.4.1. Company Description
15.2.4.2. Business Overview
15.2.4.3. Financial Overview
15.2.4.4. SWOT Analysis
15.2.5. Family Tree DNA (Gene by Gene)
15.2.5.1. Company Description
15.2.5.2. Business Overview
15.2.5.3. SWOT Analysis
15.2.6. Laboratory Corporation of America Holdings
15.2.6.1. Company Description
15.2.6.2. Business Overview
15.2.6.3. Financial Overview
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. Living DNA Ltd.
15.2.7.1. Company Description
15.2.7.2. Business Overview
15.2.7.3. SWOT Analysis
15.2.8. Medichecks.com Ltd.
15.2.8.1. Company Description
15.2.8.2. Business Overview
15.2.8.3. SWOT Analysis
15.2.9. MyHeritage Ltd.
15.2.9.1. Company Description
15.2.9.2. Business Overview
15.2.9.3. SWOT Analysis
15.2.10. MyMedLab, Inc.
15.2.10.1. Company Description
15.2.10.2. Business Overview
15.2.10.3. SWOT Analysis
15.2.11. Quest Diagnostics Incorporated
15.2.11.1. Company Description
15.2.11.2. Business Overview
15.2.11.3. Financial Overview
15.2.11.4. Strategic Overview
15.2.11.5. SWOT Analysis
List of Tables
Table 01: Global Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 02: Global Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017-2031
Table 03: Global Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017-2031
Table 04: Global Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017-2031
Table 05: Global Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017-2031
Table 06: Global Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 07: Global Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 08: Global Glycomics Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 09: North America Glycomics Market Analysis Value (US$ Mn) Forecast, by Country, 2017-2031
Table 10: North America Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 11: North America Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017-2031
Table 12: North America Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017-2031
Table 13: North America Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017-2031
Table 14: North America Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017-2031
Table 15: North America Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 16: North America Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 17: Europe Glycomics Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 18: Europe Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 19: Europe Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017-2031
Table 20: Europe Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017-2031
Table 21: Europe Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017-2031
Table 22: Europe Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017-2031
Table 23: Europe Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 24: Europe Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 25: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 26: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 27: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017-2031
Table 28: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017-2031
Table 29: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017-2031
Table 30: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017-2031
Table 31: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 32: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 33: Latin America Glycomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 34: Latin America Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 35: Latin America Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017-2031
Table 36: Latin America Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017-2031
Table 37: Latin America Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017-2031
Table 38: Latin America Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017-2031
Table 39: Latin America Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 40: Latin America Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 41: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 42: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 43: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017-2031
Table 44: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017-2031
Table 45: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017-2031
Table 46: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017-2031
Table 47: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 48: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 02: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021-2031
Figure 03: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Blood, 2017-2031
Figure 04: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017-2031
Figure 05: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017-2031
Figure 06: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017-2031
Figure 07: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 08: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 09: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Genetic Testing, 2017-2031
Figure 10: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Disease Risk Assessment Testing, 2017-2031
Figure 11: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by CBC, 2017-2031
Figure 12: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Chronic Disease Testing, 2017-2031
Figure 13: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by COVID-19 Testing, 2017-2031
Figure 14: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by TSH Testing, 2017-2031
Figure 15: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017-2031
Figure 16: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031
Figure 17: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021-2031
Figure 18: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Hospitals, 2017-2031
Figure 19: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Clinics, 2017-2031
Figure 20: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Specialty Labs, 2017-2031
Figure 21: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Diagnostic Centers, 2017-2031
Figure 22: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017-2031
Figure 23: Germany Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 24: Germany Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021-2031
Figure 25: Germany Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 26: Germany Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 27: Germany Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031
Figure 28: Germany Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021-2031
Figure 29: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017-2031
Figure 30: U.K. Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 31: U.K. Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021-2031
Figure 32: U.K. Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 33: U.K. Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 34: U.K. Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031
Figure 35: U.K. Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021-2031
Figure 36: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017-2031
Figure 37: France Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 38: France Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021-2031
Figure 39: France Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 40: France Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 41: France Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031
Figure 42: France Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021-2031
Figure 43: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017-2031
Figure 44: Italy Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 45: Italy Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021-2031
Figure 46: Italy Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 47: Italy Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 48: Italy Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031
Figure 49: Italy Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021-2031
Figure 50: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017-2031
Figure 51: Spain Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031
Figure 52: Spain Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021-2031
Figure 53: Spain Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031
Figure 54: Spain Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021-2031
Figure 55: Spain Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031
Figure 56: Spain Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021-2031

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 23andMe, Inc.
  • Ancestry
  • CircleDNA
  • Eurofins Scientific
  • Family Tree DNA (Gene by Gene)
  • Laboratory Corporation of America Holdings
  • Living DNA Ltd.
  • Medichecks.com Ltd.
  • MyHeritage Ltd.
  • MyMedLab, Inc.
  • Quest Diagnostics Incorporated